Literature DB >> 26614368

Surgical Treatment of Small Bowel Neuroendocrine Tumors.

Heather A Farley1, Rodney F Pommier2.   

Abstract

Neuroendocrine tumors of the small bowel are rare, slow-growing malignancies that commonly metastasize to nodes at the root of the mesentery and the liver. Liver metastases are associated with carcinoid syndrome. Mesenteric nodal masses can cause bowel obstruction, intestinal angina, or variceal hemorrhage. Patients die of liver failure or bowel obstruction. Primary resection is associated with improved survival rates. Selected patients may benefit from liver debulking operations. Liver resection has excellent survival rates even in the event of an incomplete resection, as well as improvement in hormonal symptoms. Radiofrequency ablation can help to preserve hepatic parenchyma during resection.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ablation; Liver; Mesenteric nodal mass; Metastasis; Neuroendocrine; Primary tumor; Resection

Mesh:

Year:  2015        PMID: 26614368     DOI: 10.1016/j.hoc.2015.09.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  12 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

Review 2.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

3.  Liver Transplantation for High-Grade Primary Hepatic Neuroendocrine Tumor with Diffuse Liver Metastasis.

Authors:  Saman Nikeghbalian; Ahad Eshraghian; Kourosh Kazemi; Alireza Shamsaeefar; Masood Hosseinzadeh; Bita Geramizadeh; Seyed Ali Malek-Hosseini
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 4.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

5.  Vitamin D and vitamin B12 deficiencies in patients with small intestinal carcinoid tumour: is opioid use disorder a confounding factor in the diagnosis?

Authors:  Richard Fagan; Syed Sabeeh Najam Bokhari; Faisal Inayat
Journal:  BMJ Case Rep       Date:  2019-03-16

Review 6.  Neuroendocrine liver metastases: a contemporary review of treatment strategies.

Authors:  Jordan M Cloyd; Aslam Ejaz; Bhavana Konda; Mina S Makary; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

7.  Carcinoid Tumor: Advances in Treatment Options.

Authors:  Urwat T Vusqa; Stuti Patel; Mamoon Ur Rashid; Deepika Sarvepalli; Abu H Khan
Journal:  Cureus       Date:  2020-01-13

8.  Midgut neuroendocrine tumor presenting with acute intestinal ischemia.

Authors:  Ioannis Mantzoros; Natalia Antigoni Savvala; Orestis Ioannidis; Styliani Parpoudi; Lydia Loutzidou; Despoina Kyriakidou; Angeliki Cheva; Vasileios Intzos; Konstantinos Tsalis
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

Review 9.  Carcinoid syndrome: update on the pathophysiology and treatment.

Authors:  Anezka C Rubin de Celis Ferrari; João Glasberg; Rachel P Riechelmann
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

10.  A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis.

Authors:  Maria Alejandra Forero Molina; Elizabeth Garcia; Deyanira Gonzalez-Devia; Rafael García-Duperly; Alonso Vera
Journal:  World Allergy Organ J       Date:  2017-09-04       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.